Cravatex Q1 Results: Consolidated profit turns positive, revenue up 39%
Cravatex Ltd posted a consolidated net profit of ₹43.81 lakh in Q1FY27, reversing a ₹136.77 lakh loss from Q1FY26. Consolidated revenue grew 39% YoY to ₹3,222.45 lakh. The profit turnaround was aided by a ₹202.36 lakh positive inventory adjustment at the group level, offsetting higher operational costs.

*this image is generated using AI for illustrative purposes only.
Cravatex Limited reported a consolidated net profit of ₹43.81 lakh for the quarter ended June 30, 2026, marking a return to profitability after recording a net loss of ₹136.77 lakh in the same period of FY26. This improvement coincided with a 39% year-on-year rise in consolidated revenue from operations to ₹3,222.45 lakh, up from ₹2,312.69 lakh in Q1FY26.
The Board of Directors approved the unaudited standalone and consolidated financial results on August 12, 2026. GPS & Associates served as the statutory auditors, issuing an unmodified limited review report on the statements prepared in accordance with Ind AS.
Financial Performance
Consolidated total income reached ₹3,662.63 lakh, driven by operating revenue and other income of ₹440.18 lakh. While purchase of stock-in-trade increased to ₹1,799.53 lakh, a favorable change in inventories of stock-in-trade amounting to ₹(202.36) lakh significantly reduced total expenses to ₹3,595.70 lakh.
| Metric: | Q1FY27 (Consolidated): | Q1FY26 (Consolidated): | Change: |
|---|---|---|---|
| Revenue from Operations: | ₹3,222.45 lakh | ₹2,312.69 lakh | +39.3% |
| Total Income: | ₹3,662.63 lakh | ₹2,833.65 lakh | +29.3% |
| Total Expenses: | ₹3,595.70 lakh | ₹2,969.81 lakh | +21.1% |
| Net Profit/(Loss): | ₹43.81 lakh | ₹(136.77) lakh | Turnaround |
| EPS (Basic): | ₹1.70 | ₹(5.29) | N/A |
On a standalone basis, Cravatex reported a net profit of ₹41.08 lakh, compared to ₹44.21 lakh in Q1FY26. Standalone revenue remained flat at ₹144.49 lakh. Other income contributed ₹139.64 lakh to standalone total income, which stood at ₹284.13 lakh.
What the Numbers Show
A notable divergence exists between the standalone and consolidated results regarding inventory management. While the standalone entity reported no change in inventories, the consolidated group recorded a positive adjustment of ₹202.36 lakh in the change in inventories of stock-in-trade. This favorable inventory movement was a key factor in narrowing the gap between total income and total expenses at the group level, enabling the turnaround to profit despite higher employee benefits expense (₹740.54 lakh vs ₹741.92 lakh) and other expenses (₹1,211.98 lakh vs ₹857.77 lakh) compared to the prior year quarter.
Historical Stock Returns for Cravatex
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.09% | -2.81% | -14.20% | -5.94% | -26.81% | +16.37% |
Will Cravatex be able to sustain its profitability in Q2FY27 given that the Q1 turnaround was largely driven by a one-time favorable inventory adjustment rather than core operational efficiency?
How does the significant divergence between flat standalone revenue and a 39% surge in consolidated revenue reflect the financial health and contribution of Cravatex's subsidiaries?
With other income contributing substantially to standalone total income (₹139.64 lakh), what is the sustainability of these non-operating gains in future quarters?


































